On the other hand, miR-4728 also demonstrates tumor-suppressive properties by inhibiting the MAPK pathway via MST4 targeting, with its downregulation in breast tumors correlating with poor patient prognosis [129]. This evidence concerns the gene STK26 and neoplasm.